ID: ALA4751164

Max Phase: Preclinical

Molecular Formula: C28H30ClN9O5S

Molecular Weight: 640.13

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(Cl)c(NCc4cccnc4N(C)S(C)(=O)=O)n3)cc2)c(=O)c1=O

Standard InChI:  InChI=1S/C28H30ClN9O5S/c1-4-21(39)30-12-13-31-22-23(25(41)24(22)40)33-14-17-7-9-19(10-8-17)36-28-35-16-20(29)26(37-28)34-15-18-6-5-11-32-27(18)38(2)44(3,42)43/h4-11,16,31,33H,1,12-15H2,2-3H3,(H,30,39)(H2,34,35,36,37)

Standard InChI Key:  COBUBKXVXDHVBG-UHFFFAOYSA-N

Associated Targets(Human)

Protein tyrosine kinase 2 beta 2827 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Focal adhesion kinase 1 4730 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tyrosine-protein kinase SRC 10310 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Fibroblast growth factor receptor 1 9149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Stem cell growth factor receptor 10667 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Epidermal growth factor receptor erbB1 33727 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Insulin-like growth factor I receptor 8605 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Platelet-derived growth factor receptor alpha 5682 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Insulin receptor 5558 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serine/threonine-protein kinase AKT 245 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 640.13Molecular Weight (Monoisotopic): 639.1779AlogP: 2.20#Rotatable Bonds: 15
Polar Surface Area: 187.41Molecular Species: NEUTRALHBA: 12HBD: 5
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.49CX Basic pKa: 4.54CX LogP: 1.42CX LogD: 1.42
Aromatic Rings: 4Heavy Atoms: 44QED Weighted: 0.07Np Likeness Score: -1.23

References

1. Li B,Li Y,Tomkiewicz-Raulet C,Dao P,Lietha D,Yen-Pon E,Du Z,Coumoul X,Garbay C,Etheve-Quelquejeu M,Chen H.  (2020)  Design, Synthesis, and Biological Evaluation of Covalent Inhibitors of Focal Adhesion Kinase (FAK) against Human Malignant Glioblastoma.,  63  (21): [PMID:33119295] [10.1021/acs.jmedchem.0c01059]

Source